Uniindia: Thiruvananthapuram, Jan 16 (UNI) Researchers at the Rajiv Gandhi Centre for Biotechnology (RGCB) here have identified Cyclophilin A, a protein which is a known player in several human diseases, as a potential drug target for reducing risk of heart disease in patients with diabetes.